Adrian Gottschalk - Aug 20, 2021 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Chief Executive Officer, Director
Signature: /s /Allan Reine, M.D., Attorney-in-Fact for Adrian Gottschalk
Stock symbol: FHTX
Transactions as of: Aug 20, 2021
Transactions value $: $12,420
Form type: 4
Date filed: 8/23/2021, 05:01 PM
Next filing: Jan 28, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FHTX	Common Stock	Options Exercise	$12.4K	+23K	+5.43%	$0.54^*	446K	Aug 20, 2021	Direct
holding	FHTX	Common Stock						25.2K	Aug 20, 2021	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FHTX	Stock Options (Right to buy)	Options Exercise	$0	-23K	-4.77%	$0.00	459K	Aug 20, 2021	Common Stock	23K	$0.54	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
F2	The option vested as to 25% of the underlying shares of common stock on May 30, 2018, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.